Plasma concentration of Amino-Terminal Pro-Brain natriuretic peptide in chronic heart failure: Prediction of cardiovascular events and interaction with the effects of rosuvastatin a report from CORONA

Abstract

A significant interaction exists between the effects of rosuvastatin and the plasma concentration of B-type natriuretic peptide, or NT-proBNP, resp. Rosuvastatin decreases rate of major cardiovascular events (CV-death + myocardial infarction + stroke) only in the patients with chronic heart failure and low NT-proBNP plasma concentration.

Keywords

• Cardiac resynchronization therapy
• mortality
• atorvastatin
• morbidity
• diagnosis
• BNP